Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases

OBJECTIVES: The efficacy of a partial agonist for the dopamine D(2) receptor, aripiprazole, for catatonia in schizophrenia has been reported. METHODS: We report distinct clinical courses in challenging aripiprazole to treat residual mutism after severe catatonic symptoms improved. RESULTS: In the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Muneoka, Katsumasa, Kanahara, Nobuhisa, Kimura, Shou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315413/
https://www.ncbi.nlm.nih.gov/pubmed/28255444
http://dx.doi.org/10.1177/2050313X17692936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315413/
https://www.ncbi.nlm.nih.gov/pubmed/28255444
http://dx.doi.org/10.1177/2050313X17692936

Ejemplares similares